<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0003584'>Late-onset</z:hpo> <z:hpo ids='HP_0000135'>hypogonadism</z:hpo> (LOH) or age-associated <z:chebi fb="51" ids="17347">testosterone</z:chebi> deficiency syndrome is defined as a clinical and biochemical syndrome associated with advancing age and characterised by symptoms and a deficiency in serum <z:chebi fb="51" ids="17347">testosterone</z:chebi> levels </plain></SENT>
<SENT sid="1" pm="."><plain>This condition may result in significant detriment in the quality of life and adversely affect the function of multiple organ systems </plain></SENT>
<SENT sid="2" pm="."><plain>It has been suggested that sex steroid hormones may play a causal role in the development of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and type II <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>This comparative study was aimed at determining the prevalence of LOH in diabetic men with <z:hpo ids='HP_0000802'>erectile dysfunction</z:hpo> and investigating the effect of <z:chebi fb="51" ids="17347">testosterone</z:chebi> replacement therapy on erectile function and on glycaemic control </plain></SENT>
</text></document>